Publicaties
Visceral leishmaniasis IgG1 rapid monitoring of cure vs. relapse, and potential for diagnosis of post kala-azar dermal leishmaniasis Instituut voor Tropische Geneeskunde Universiteit Antwerpen Vrije Universiteit Brussel
Background: There is a recognized need for an improved diagnostic test to assess post-chemotherapeutic treatment outcome in visceral leishmaniasis (VL) and to diagnose post kala-azar dermal leishmaniasis (PKDL). We previously demonstrated by ELISA and a prototype novel rapid diagnostic test (RDT), that high anti-Leishmania IgG1 is associated with post-treatment relapse versus cure in VL.
Methodology: Here, we further evaluate this ...
Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis Instituut voor Tropische Geneeskunde
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post Kala azar dermal leishmaniasis Instituut voor Tropische Geneeskunde
Leishmaniasis in the Sudan. II. Field evaluation of the direct agglutination test kit for the routine diagnosis of visceral leishmaniasis (DAT-VL Kit) in Gedaref area, Eastern Sudan; preliminary results Instituut voor Tropische Geneeskunde
Epidemiological study of canine leishmaniasis in Algeria and its impact on the human visceral leishmaniasis Instituut voor Tropische Geneeskunde
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post Kala-azar dermal leishmaniasis Universiteit Antwerpen
Leishmaniasis in the lowlands of Bolivia (Leishbol). Part I: An overview of the integrated project for the characterization, vigilance and control of leishmaniasis Instituut voor Tropische Geneeskunde
Drug resistance and treatment failure in leishmaniasis Instituut voor Tropische Geneeskunde Universiteit Antwerpen
Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem. Drug resistance is a fundamental determinant of treatment failure, although other factors also contribute to this phenomenon, including the global HIV/AIDS epidemic with its accompanying impact on the immune system. Pentavalent antimonials have been used successfully worldwide for ...